A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
NCT02503163 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2017-11-17
Summary
The purpose of this study is to evaluate of the long-term safety and efficacy of KCT-0809 in dry eye patients with Sjögren's syndrome.
Conditions
- Dry Eye With Sjögren's Syndrome
Interventions
- DRUG
-
KCT-0809 ophthalmic solution
Sponsors & Collaborators
-
Kissei Pharmaceutical Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Primary Completion
- 2017-10-19
Countries
- Japan
More Related Trials
-
A Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01211951 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease
NCT03216096 ·Status: COMPLETED ·Phase: PHASE1
-
MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome
NCT07185139 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome
NCT00233363 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye
NCT06411132 ·Status: TERMINATED
-
Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome
NCT07277257 ·Status: RECRUITING ·Phase: PHASE4
-
Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes
NCT00721656 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483 ·Status: COMPLETED ·Phase: PHASE2
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome
NCT02011776 ·Status: COMPLETED
-
Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01101984 ·Status: COMPLETED ·Phase: NA
-
Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögren's Syndrom
NCT07171710 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Exosome-miRNA and Transcriptome Profiling of Dry Eye Syndrome and Sjogren's Syndrome
NCT06475027 ·Status: NOT_YET_RECRUITING
-
Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome
NCT02147509 ·Status: COMPLETED ·Phase: NA
-
A Study of AG-80308 in Dry Eye Patients
NCT05372107 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome
NCT00852839 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
NCT01488396 ·Status: COMPLETED ·Phase: PHASE4
-
Study of TOP1630 for Dry Eye Syndrome
NCT03833388 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
NCT02254265 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome
NCT02774707 ·Status: UNKNOWN
-
AST Combined With 0.05% Cyclosporin Eye Drop Improve Corneal Nerve Density in Patients With SS Dry Eye
NCT06013436 ·Status: COMPLETED
-
Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
NCT04819269 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety and Immunological Evaluation of Tofacitinib in the Treatment of Primary Sjogren's Syndrome
NCT05087589 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of TOP1630 for Dry Eye Syndrome
NCT03088605 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of LO2A Eye Drops for Symptomatic Improvement of Dry Eye in Patients With Sjögren's Syndrome
NCT03319420 ·Status: COMPLETED ·Phase: PHASE4